The Presidential Initiative for Unlocking the Healthcare Value Chain (PVAC) welcomes investments
that strengthen Nigeria’s capacity to produce essential health products locally and improve long-term
medicine security. In that context, Emzor’s Active Pharmaceutical Ingredients (API) project is relevant
to the broader national effort to deepen domestic pharmaceutical manufacturing and reduce structural
dependence on imported inputs.
PVAC’s mandate is to help unlock the healthcare value chain through cross-sector coordination,
policy enablement, investment facilitation, technical partnerships, and support for local manufacturing
across priority value chains. This includes advancing the conditions required for Nigeria to increase
local production, create quality jobs, attract capital, strengthen supply resilience, and position the
country as a competitive health manufacturing hub in Africa.
API production is one of PVAC’s priority areas because it sits at the foundation of pharmaceutical
self-reliance. The development of local API capacity supports national objectives on medicine
availability, affordability, health security, and industrial growth, while also contributing to Nigeria’s
ambition to serve regional markets under frameworks such as AfCFTA.
Within this broader vision, Emzor’s project reflects the kind of industrial capacity expansion that can
support national healthcare goals if executed to high quality, regulatory, and market standards. Its
focus on local API manufacturing aligns with ongoing efforts to stimulate domestic production,
strengthen supply chains, and expand the range of health products and technologies that can be made
in Nigeria.
PVAC therefore recognizes the strategic relevance of initiatives such as Emzor’s API project to the
sector’s development and to the implementation of the Federal Government’s healthcare value chain
agenda specifically, initiatives like the Affordable Diagnostics and Medicines for Malaria Funding
model (ADMFm).
By demonstrating long-term commitment to high-quality local API manufacturing,
beginning with antimalarials, Emzor is contributing in a tangible way to national goals on medicine
security, industrial growth and regional competitiveness, and exemplifying the kind of private-sector
leadership PVAC seeks to enable across the pharmaceutical value chain